Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts

Annals of Vascular Surgery

Volumn 17, Issue 4, 2003, Pages 401-407

  Sala, Florent ^a   Hassen Khodja, Reda ^a   Lecis, Alexandre ^a   Bouillanne, Pierre Jean ^a   Declemy, Serge ^a   Batt, Michel ^a  

^a University Hospital of Nice University of Nice Sophia Antipolis   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; AGED; ANEURYSM; ARTERIOGRAPHY; ARTERY OCCLUSION; AUTOGRAFT; CONFERENCE PAPER; FEMALE; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; FOLLOW UP; HUMAN; ISCHEMIA; LEG; MAJOR CLINICAL STUDY; MALE; POLITEF IMPLANT; POPLITEAL ARTERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SAPHENOUS VEIN; SURGICAL MORTALITY; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN GRAFT;

EID: 0141446082     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-003-0019-9     Document Type: Conference Paper

References (33)

1. Londrey GL, Ramsey DE, Hodgson KJ, et al. Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg 1991;13:631-636.
2. Rutherford RB, Jones DN, Bergentz SE, et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988;8:236-246.
3. Tordoir JH, van der Plas JP, Jacobs MJ, Kitslaar PJ. Factors determining the outcome of crural and pedal revascularisation for critical limb ischemia. Eur J Vasc Surg 1993;7:82-86.
4. Veith FJ, Gupta SK, Ascer E, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114.
5. Plecha EJ, Freischlag JA, Seabrook GR, Towne JB. Femoropopliteal bypass revisited: an analysis of 138 cases. Cardiovasc Surg 1996;4:195-199.
6. Poletti LF, Matsuura JH, Dattilo JB, et al. Doit-on épargner le capital veineux en vue de futures interventions? 15 ans d'études des besoins en veine autogène après revascularisation sous-inguinale. Ann Chir Vasc 1998;12:143-147.
7. Taylor Jr LM, Edwards JM, Porter JM. Present status of reversed vein bypass grafting: five-year results of a modern series. J Vasc Surg 1990;11:193-206.
8. Wilson YG, Wyatt MG, Currie IC, et al. Preferential use of vein for above-knee femoropopliteal grafts. Eur J Vasc Endovasc Surg 1995;10:220-225.
9. Abbott WM, Green RM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 1997;25:19-28.
10. Allen BT, Reilly JM, Rubin BG, et al. Femoropopliteal bypass for claudication: vein vs PTFE. Ann Vasc Surg 1996;10:178-185.
11. John TG, Stonebridge PA, Kelman J, et al. Above-knee femoropopliteal bypass grafts and the consequences of graft failure. Ann R Coll Surg Engl 1993;75:257-260.
12. O'Riordain DS, Buckley DJ, O'Donnell JA. Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 1992;164:129-131.
13. Patterson RB, Fowl RJ, Kempczinski RF, et al. Preferential use of ePTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg 1990;4:338-343.
14. Prendiville EJ, Yeager A, O'Donnell Jr TF, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11:517-524.
15. Quiñones-Baldrich WJ, Prego AA, Ucelay-Gomez R, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg 1992;16:209-217.
16. Rosenthal D, Evans RD, McKinsey J, et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg 1990;31:462-468.
17. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000;31:S1-S296.
18. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-277.
19. AbuRahma AF, Robinson PA, Holt SM. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 1999;126:594-602.
20. Burger DH, Kappetein AP, Van Bockel JH, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 2000;32:278-283.
21. Archie Jr JP. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann Vasc Surg 1994;8:475-484.
22. Curi MA, Skelly CL, Meyerson SL, et al. Conduit choice for above-knee femoropopliteal bypass grafting in patients with limb-threatening ischemia. Ann Vasc Surg 2002;16:95-101.
23. Mills Sr JL. P values may lack power: the choice of conduit for above-knee femoropopliteal bypass graft. J Vasc Surg 2000;32:402-405.
24. Tarry WC, Walsh DB, Birkmeyer NJ, et al. Fate of the contralateral leg after infrainguinal bypass. J Vasc Surg 1998;27:1039-1048.
25. Abbott WM. Prosthetic above-knee femoral-popliteal bypass: indications and choice of graft. Semin Vasc Surg 1997;10:3-7.
26. Devine C, Hons B, McCollum C. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 2001;33:533-539.
27. Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 2000;31:417-425.
28. Post S, Kraus T, Muller-Reinartz U, et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomized multicentre trial. Eur J Vasc Endovasc Surg 2001;22:226-231.
29. Robinson BI, Fletcher JP, Tomlinson P, et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg 1999;7:214-218.
30. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 2000;355:346-351.
31. Prendiville EJ, Yeager A, O'Donnell Jr TF, et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 1990;11:517-524.
32. Tangelder MJ, Algra A, Lawson JA, Eikelboom BC. Risk factors for occlusion of infrainguinal bypass grafts. Eur J Vasc Endovasc Surg 2000;20:118-124.
33. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. The Joint Vascular Research Group. J Vasc Surg 1977;26:543-550.